Titan Pharmaceuticals
TTNP
#10414
Rank
ยฃ4.59 M
Marketcap
ยฃ3.46
Share price
-3.76%
Change (1 day)
17.56%
Change (1 year)

Revenue for Titan Pharmaceuticals (TTNP)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of ยฃ0 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Titan Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 ยฃ0 M-98.44%
2022 ยฃ0.05 M-72.67%
2021 ยฃ0.18 M66.52%
2020 ยฃ0.11 M-89%
2019 ยฃ1 M-78.37%
2018 ยฃ4.65 M2827.72%
2017 ยฃ0.15 M-98.7%
2016 ยฃ12.2 M982.77%
2015 ยฃ1.12 M-51.84%
2014 ยฃ2.34 M-63.15%
2013 ยฃ6.35 M44.3%
2012 ยฃ4.4 M68.24%
2011 ยฃ2.61 M-59.97%
2010 ยฃ6.53 M13292.45%
2009 ยฃ0.04 M
2006 ยฃ0.01 M-68.35%
2005 ยฃ0.05 M
2002 ยฃ1.8 M-42.8%
2001 ยฃ3.15 M150.34%
2000 ยฃ1.25 M484.86%
1999 ยฃ0.21 M19.37%
1998 ยฃ0.18 M-98.33%
1997 ยฃ10.77 M3589.99%
1996 ยฃ0.29 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Vanda Pharmaceuticals
VNDA
ยฃ0.15 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
ยฃ0.1 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ1.95 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.11 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ42.28 BN/A๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
ยฃ0.53 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA